Is Shree Pacetronix the Best Stock in Its Sector? A Look at the Numbers

Is Shree Pacetronix the best stock in its sector? The stock trades on the BSE at Rs 159 as of 22 October 2026, within its 52-week range of Rs 90.00 to Rs 283.15. The sections below cover the business, the key ratios, a peer comparison and a closer look at valuation.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

About Shree Pacetronix

Shree Pacetronix Ltd is in the business of cardiac rhythm devices such as pacemakers, and company information says it was incorporated in 1988. Company information says it delivers MRI safe, life saving critical medical devices that regulate heart rhythms and improve quality of life for patients with cardiac conditions such as arrhythmias and heart failure. At a market capitalisation of Rs 60 Cr, it is tracked as part of the Cardiac Medical Devices sector on Univest.

Is Shree Pacetronix the Best Stock in Its Sector?

Shree Pacetronix makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, backed by its return on equity. Shree Pacetronix's 18.48x P/E is below the 59.59x Industry P/E, Poly Medicure at 47.46x and Laxmi Dental at 35.28x, while its 17.36% ROE is higher than Poly Medicure at 10.37% and Laxmi Dental at 13.74%, and its debt to equity ratio of 0.15 is above Poly Medicure at 0.11 and Laxmi Dental at 0.05.

Metric	Shree Pacetronix
CMP (BSE)	Rs 159.45
52-Week High / Low	Rs 283.15 / Rs 90.00
Market Cap	Rs 60 Cr
P/E (TTM) vs Industry P/E	18.48x vs 59.59x
P/B	3.36
ROE	17.36%
EPS (TTM)	Rs 8.63
Dividend Yield	0.00%
Debt to Equity	0.15

Compare Shree Pacetronix Against Other Cardiac Medical Devices Sector Stocks

How Shree Pacetronix Compares Against Its Cardiac Medical Devices Sector Peers

The table below sets Shree Pacetronix against 2 other Cardiac Medical Devices sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.

Company	Market Cap (Rs Cr)	P/E	ROE	Debt to Equity
Shree Pacetronix	60	18.48	17.36%	0.15
Poly Medicure	14,850	47.46	10.37%	0.11
Laxmi Dental	1,091	35.28	13.74%	0.05
Peer average (2 companies)	-	41.37	12.05%	0.08

Measured against the peer averages, Shree Pacetronix's P/E is 55 percent below the 41.37x average, and its ROE is 5.30 percentage points above the 12.05% average. An average of just two companies is a rough guide, so treat the gap as a pointer for further research and not as a verdict.

What Makes Shree Pacetronix Worth Watching in Cardiac Medical Devices

• Scale: At Rs 60 Cr, its market capitalisation is smaller than Poly Medicure (Rs 14,850 Cr) and Laxmi Dental (Rs 1,091 Cr), which is a useful reminder that the peers differ in size as well as in valuation.
• Sector drivers: Demand for cardiac devices from hospitals, approvals for new products and the margin on each device drive revenue and earnings.
• Key risk: Medical device sales depend on regulatory approvals and hospital purchasing, which can be slow. Limited trading volumes can also move the price sharply.

Shree Pacetronix Valuation: Is It Justified?

At a P/B ratio of 3.36, the market pays about Rs 3.36 for every rupee of book value, and the EPS (TTM) of Rs 8.63 is the earnings base behind the P/E. The stock trades about 44 percent below its 52-week high and about 77 percent above its 52-week low. The company does not currently show a dividend yield, so returns for shareholders depend mainly on the share price. As with any single stock, investors should weigh these figures against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is Oracle Financial Services Software the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track Shree Pacetronix and other Cardiac Medical Devices sector stocks.

How to Track Shree Pacetronix Before You Invest

Before deciding whether Shree Pacetronix deserves its label as the best stock in its sector for your own portfolio, compare it directly against Cardiac Medical Devices sector peers using the steps below.

1. Open the Univest Screener and search for Shree Pacetronix to view live price, valuation ratios, and peer comparisons within the Cardiac Medical Devices sector.
2. Compare its P/E, P/B, and ROE against other Cardiac Medical Devices sector stocks before deciding if the current valuation fits your strategy.
3. Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
4. Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

Shree Pacetronix gives investors a clear set of numbers to work with, from returns and valuation to leverage and peer standing. Whether it earns the label of best stock in Cardiac Medical Devices depends on how much weight you give each of them and on how the business executes from here. Because the stock trades below its sector benchmark, the open question is whether earnings growth will close that gap or whether the discount is deserved. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Is Shree Pacetronix the best stock in its sector?

Ans. There is no single definitive answer, because the best stock in a sector depends on whether an investor is prioritising returns, valuation or balance sheet strength. Shree Pacetronix has a 17.36% ROE and trades at 18.48x P/E against a 59.59x Industry P/E. Against the 2 peers compared in this article, its ROE is above the 12.05% peer average and its P/E is below the 41.37x peer average. Its debt to equity ratio of 0.15 is above the 0.08 peer average, which matters because borrowing can inflate returns and add risk when business conditions weaken. These figures are best read together rather than in isolation, and they work as a starting point for your own research and not as a verdict.

What is the current share price of Shree Pacetronix?

Ans. Shree Pacetronix was trading at Rs 159.45 on the BSE as of 22 October 2026, and its 52-week range runs from Rs 90.00 to Rs 283.15. That leaves the share price 44 percent short of the 52-week high and 77 percent clear of the 52-week low. Its market capitalisation is Rs 60 Cr and its EPS (TTM) is Rs 8.63, which is the earnings figure behind the 18.48x P/E. Share prices change through the trading day, so check the live quote on Univest before acting on any number here.

What sector does Shree Pacetronix belong to?

Ans. Shree Pacetronix is classified under the Cardiac Medical Devices sector on Univest, and that group of listed companies is the reference point for the 59.59x Industry P/E used in this article. The 2 named peers compared here are Poly Medicure and Laxmi Dental, chosen as comparable listed names so that the P/E, ROE and debt figures come from the same live data source. Investors who want a wider view can compare more Cardiac Medical Devices sector stocks on the Univest Screener, since no two companies in a sector have exactly the same business mix.

How does Shree Pacetronix compare to its sector peers on P/E?

Ans. Shree Pacetronix's P/E of 18.48x is below the 41.37x average of the 2 named peers, with Poly Medicure at 47.46x and Laxmi Dental at 35.28x. It also sits below the 59.59x Industry P/E, which is the benchmark for the wider Cardiac Medical Devices sector. A P/E that is below a peer average can reflect a valuation discount or premium, but it can also reflect different growth or return expectations, so it should be read alongside ROE and debt. Its P/B ratio of 3.36 gives one more view of how the market values its book value.

What is Shree Pacetronix's return on equity?

Ans. Shree Pacetronix reported a return on equity of 17.36%, which is above the 12.05% average of its named peers, with Poly Medicure at 10.37% and Laxmi Dental at 13.74%. ROE shows how much profit a company generates on every rupee of shareholders' equity, so a higher figure generally points to more efficient use of capital. ROE is easier to trust when leverage is modest, and here the debt to equity ratio is 0.15 against a peer average of 0.08. It is worth checking whether the ROE has been stable over several years rather than relying on a single reading.

Should I invest in Shree Pacetronix based on its sector position?

Ans. Sector position is only one input into an investment decision. Shree Pacetronix has a 17.36% ROE and a 18.48x P/E, which make it worth researching further, and its dividend yield is 0.00%. You should also weigh its business outlook, earnings consistency, debt levels, your investment horizon and your own risk appetite before buying. Spreading money across several stocks and sectors reduces concentration risk, and this article is educational content, not investment advice. For personalised guidance, consult a SEBI-registered advisor.